Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials

Data from 2 randomized liver transplant trials (N = 772; H2304 [deceased donor, n = 488], H2307 [living donor, n = 284]) were pooled to further evaluate the efficacy and safety of everolimus with reduced tacrolimus (EVR + rTAC) versus standard tacrolimus (sTAC) regimen at month 24. RESULTS. EVR + rT...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sung-Gyu, Jeng, Long-Bin, Saliba, Faouzi, Singh Soin, Arvinder, Lee, Wei-Chen, De Simone, Paolo, Nevens, Frederik, Suh, Kyung-Suk, Fischer, Lutz, Jin Joo, Dong, Fung, John, Joh, Jae-Won, Kaido, Toshimi, Grant, David, Meier, Matthias, Rauer, Barbara, Sips, Carole, Kaneko, Shuhei, Levy, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Clinical Science—Liver
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221719/
https://www.ncbi.nlm.nih.gov/pubmed/33741847
http://dx.doi.org/10.1097/TP.0000000000003394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221719/
https://www.ncbi.nlm.nih.gov/pubmed/33741847
http://dx.doi.org/10.1097/TP.0000000000003394

Ejemplares similares